Noscapine Hcl Sam (Noscapine Hydrochloride)

Noscapine Hydrochloride, the active ingredient in Noscapine Hcl Sam, is an alkaloid antitussive presented as an oral dosage form for oral use. It is employed to suppress cough in patients requiring symptomatic relief of non‑productive cough.

GNH USA supplies Noscapine Hcl Sam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across markets. The company adheres to stringent manufacturing standards and provides reliable logistics for global distribution.

Noscapine Hydrochloride is used as a central antitussive agent to control cough.

- Cough (non‑productive): Reduces the frequency and intensity of dry cough episodes. - Acute bronchitis (dry cough): Provides symptomatic relief of cough associated with acute bronchitis. - Post‑viral cough: Helps alleviate lingering cough after viral respiratory infections.

Adverse reactions to Noscapine Hydrochloride are generally mild but can vary in severity.

Common Side Effects: - Nausea: Mild to moderate upset stomach. - Dizziness: Transient light‑headedness. - Drowsiness: Slight sedation, especially at higher doses. - Headache: Occasional tension‑type headache. - Gastrointestinal discomfort: Mild abdominal cramps or dyspepsia. - Rash: Minor skin erythema.

Serious or Rare Side Effects: - Allergic reaction: Hives, swelling, or anaphylaxis. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: Elevated liver enzymes or jaundice. - Hematologic effects: Neutropenia or thrombocytopenia. - Seizures: Rare occurrence, particularly in predisposed individuals.

When prescribing Noscapine Hydrochloride, clinicians should consider several safety measures.

- Hypersensitivity assessment: Verify no known allergy to noscapine or related alkaloids. - Hepatic function: Use caution in patients with liver impairment and monitor liver enzymes. - Pregnancy and lactation: Evaluate risk‑benefit, as safety data are limited. - Concomitant CNS depressants: Observe for additive sedation. - Renal impairment: Adjust monitoring if severe renal dysfunction is present. - Store at ambient temperature: Keep below 25°C, retain in original packaging, protect from moisture and direct sunlight.

Noscapine Hydrochloride may interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - CNS depressants (e.g., benzodiazepines, opioids): May potentiate sedation and respiratory depression. - Other antitussives (e.g., dextromethorphan): Combined use can increase risk of central nervous system side effects.

Moderate Interactions (Monitor Closely): - CYP450 substrates (e.g., warfarin, phenytoin): Potential for altered plasma levels; monitor therapeutic response. - Antihistamines: May enhance drowsiness; advise patient to avoid hazardous activities. - Alcohol: Can increase central effects; counsel on limited intake.